Skip to main content
. 2020 Jan 16;28(1):159–169. doi: 10.1007/s40199-020-00326-z

Fig. 2.

Fig. 2

Representative dot plot graph showing frequency of early and late apoptotic death after 48 h treatment of (a) B16F10 cells with DOX, stattic and DOX + stattic and (b) CT26 cells with DOX, OXP, stattic, DOX + stattic and OXP + stattic, as assessed by Annexin/PI staining and analyzed by flow cytometry. Each experiment was conducted in triplicate. DOX, doxorubicin; and OXP, oxaliplatin